Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma

Abstract

Background The Notch signaling pathway is constitutively activated in human cutaneous melanoma to promote growth and aggressive metastatic potential of primary melanoma cells. Therefore, genetic variants in Notch pathway genes may affect the prognosis of cutaneous melanoma patients. Methods We identified 6,256 SNPs in 48 Notch genes in 858 cutaneous melanoma patients included in a previously published cutaneous melanoma genome-wide association study dataset. Multivariate and stepwise Cox proportional hazards regression and false-positive report probability corrections were performed to evaluate associations between putative functional SNPs and cutaneous melanoma disease-specific survival. Receiver operating characteristic curve was constructed, and area under the curve was used to assess the classification performance of the model. Results Four putative functional SNPs of Notch pathway genes had independent and joint predictive roles in survival of cutaneous melanoma patients. The most significant variant was NCOR2 rs2342924 T>C (adjusted HR, 2.71; 95% confidence interval, 1.73–4.23; Ptrend = 9.62 × 10−7), followed by NCSTN rs1124379 G>A, NCOR2 rs10846684 G>A, and MAML2 rs7953425 G>A (Ptrend = 0.005, 0.005, and 0.013, respectively). The receiver operating characteristic analysis revealed that area under the curve was significantly increased after adding the combined unfavorable genotype score to the model containing the known clinicopathologic factors. Conclusions Our results suggest that SNPs in Notch pathway genes may be predictors of cutaneous melanoma disease-specific survival. Impact Our discovery offers a translational potential for using genetic variants in Notch pathway genes as a genotype score of biomarkers for developing an improved prognostic assessment and personalized management of cutaneous melanoma patients.

Inherited functional variants of the lymphocyte receptor CD5 influence melanoma survival

“…SNPs in Nucleotide Excision Repair (NER) and Poly [ADP‐Ribose] Polymerase 1 ( PARP1 ) genes have also been implicated in melanoma prognosis, showing the relevance of the DNA damage and repair system for tumor survival . A similar situation applies to genes from the Hippo pathway, which control cell migration, development and organ sizes in diverse species, as well as genes from the Notch and Fanconi anemia pathways. Related with immunity, SNPs in the interleukin locus and angiogenesis have also been associated with melanoma progression …”

Variants in Notch signalling pathway genes, PSEN1 and MAML2, predict overall survival in Chinese patients with epithelial ovarian cancer

“…The effects of genetic variants in Notch signalling pathway genes on survival of cancer patients have been identified in several cancer types, including cutaneous melanoma,20 non‐small‐cell lung cancer 7 and hepatocellular cancer 21. In addition, the deregulation of Notch signalling pathway genes is also involved in the development of platinum resistance and recurrence of EOC 22.…”

Genetic variants in the PIWI‐piRNA pathway gene DCP1A predict melanoma disease‐specific survival

“…As described previously, all patients in the discover GWAS were accrued for a hospital‐based case‐control study of CM at The University of Texas MD Anderson Cancer Center (MDACC). Characteristic details of the subjects have also been previously described . Briefly, all patients with CM stages I/II (primary tumors without evidence of regional or distant metastasis), stage III (locoregional disease, including in transit, satellite, and/or regional lymph node metastasis), and stage IV (distant metastasis) were classified according to the 7th edition of the American Joint Committee on Cancer (AJCC) staging system .…”